# Efficacy and Safety of Salvianolic Acid on AIS

> **NCT04931628** · NA · TERMINATED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 1 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Salvianolic Acid
- **DRUG:** 0.9% NaCl

## Key facts

- **NCT ID:** NCT04931628
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-03
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** negative information
- **Last updated:** 2023-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931628, "Efficacy and Safety of Salvianolic Acid on AIS". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04931628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*